Hillenbrand sells majority stake in Milacron injection molding and extrusion business for $287M

sergeyryzhov/iStock via Getty Images Hillenbrand ( NYSE: HI ) +4.6% pre-market Tuesday after saying it completed the previously announced sale of its majority interest in the Milacron injection molding and extrusion business to Bain Capital for $287M. Bain Capital now owns a 51% share and has full operational.